Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · May 06, 2022

Bevacizumab Plus Atezolizumab Following Progression on Atezolizumab Monotherapy in Pretreated Patients With NSCLC

Journal of Thoracic Oncology


Additional Info

Disclosure statements are available on the authors' profiles:

Journal of Thoracic Oncology
Bevacizumab plus atezolizumab following progression on atezolizumab monotherapy in pretreated non-small cell lung cancer patients: An open-label, two-stage, phase II trial
J Thorac Oncol 2022 Apr 12;[EPub Ahead of Print], J Lee, J Koh, HK Kim, S Hong, K Kim, S Park, HA Jung, JM Sun, SH Lee, JS Ahn, K Park, MJ Ahn

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading